Clinical Trial Update: Shorter and Safer Treatment Regimens for Latent TB [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update indicates ongoing Phase 2/3 evaluations of shorter and safer treatment regimens for latent tuberculosis infection, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Latent Tuberculosis Infection

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Tuberculosis Infection, Latent | Phase 2, Phase 3 | Status: RECRUITING